Position in FATE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,569,435
+$460,921 QoQ
Shares Held
1,322,013
-49.0% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. FATE ranks #269 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in FATE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,569,435 | 1,322,013 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,108,514 | 2,590,429 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,418,980 | 2,468,348 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $3,188,066 | 2,530,212 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,720,666 | 2,429,167 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,792,990 | 2,269,609 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,674,494 | 2,226,967 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $7,903,860 | 2,258,246 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,371,416 | 2,247,383 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $13,989,915 | 1,905,983 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,969,433 | 1,863,485 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,763,729 | 1,775,344 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,306,733 | 1,745,112 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,191,757 | 1,612,589 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,783,696 | 1,564,291 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $33,607,828 | 1,499,680 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $36,319,500 | 1,465,678 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $57,155,780 | 1,474,227 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $83,433,387 | 1,425,968 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $83,220,769 | 1,404,096 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $123,103,456 | 1,418,406 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $111,250,774 | 1,349,312 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $105,434,608 | 1,159,514 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $44,106,495 | 1,103,490 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $35,384,795 | 1,031,326 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $21,072,581 | 948,788 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||